NCT01418495
- Conditions
- Chemically-Induced Disorders, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, +21 more
- Locations
-
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
Clinical trial condition
Neurotoxicity Syndrome
Explore clinical trials studying Neurotoxicity Syndrome. Study availability and eligibility vary by location and protocol.
4 public trials
0 recruiting studies
Neurotoxicity Syndrome trial results
NCT00437060
- Conditions
- Chemically-Induced Disorders, Childhood B Acute Lymphoblastic Leukemia, Childhood T Acute Lymphoblastic Leukemia, +8 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Southern California Permanente Medical Group Downey, California, United States
- Miller Children's and Women's Hospital Long Beach Long Beach, California, United States
NCT02311907
- Conditions
- Adnexal Diseases, Chemically-Induced Disorders, Chemotherapeutic Agent Toxicity, +37 more
- Locations
-
- Providence Hospital Mobile, Alabama, United States
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Northbay Cancer Center Fairfield, California, United States
NCT00814086
- Conditions
- Adnexal Diseases, Brenner Tumor, Chemically-Induced Disorders, +40 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
- Cooper Hospital University Medical Center Camden, New Jersey, United States
- Riverside Methodist Hospital Columbus, Ohio, United States